Surgical Endoscopy

, Volume 22, Issue 2, pp 566–572 | Cite as

Randomized clinical trial comparing oral prednisone (50 mg) with placebo before laparoscopic cholecystectomy

  • Thue BisgaardEmail author
  • Svend Schulze
  • Niels Christian Hjortsø
  • Jacob Rosenberg
  • Viggo Bjerregaard Kristiansen



Intravenous administration of dexamethasone 90 min before laparoscopic cholecystectomy improves surgical outcome but may be impractical. The objective of this study was to assess the clinical efficacy of oral self-administration of prednisone 2 h before ambulatory laparoscopic cholecystectomy.


In a double-blind placebo-controlled study, 200 patients were randomized to oral administration of prednisone (50 mg) or placebo 2 h before laparoscopic cholecystectomy. Patients received a similar standardized anaesthetic, surgical, and analgesic treatment. The primary outcome was pain 24 h after surgery and secondary outcomes were fatigue and malaise 24 h after surgery. Outcome parameters were registered before operation, on the day of operation, and the following two days. Analgesic and antiemetic requirements were registered, and nausea and vomiting were assessed twice within the first 24 h. Side-effects and 30-day follow-up for morbidity were registered.


Data from 184 patients were available for statistical analysis. There were no significant differences in side-effects or complications between the surgical groups (> 0.05). No significant intergroup differences in 24-h pain, fatigue or malaise scores or any other variables were found (> 0.05).


There is no important clinical gain of preoperative oral steroid administration compared with placebo in patients undergoing laparoscopic cholecystectomy.


Cholecystectomy Prednisone Corticosteroids Pain Fatigue Nausea and vomiting Outcome 



The authors would like to thank Nycomed Danmark A/S, Denmark for providing randomized concealed containers of the study drugs for the trial. Research nurses Dorthe Greve Jørgensen, Jeanette Juncker Madsen, and Irene Tarp Jørgensen are thanked for invaluable help and enthusiasm during the study.


  1. 1.
    Bisgaard T, Klarskov B, Kehlet H, Rosenberg J (2003) Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy. A randomized double-blind placebo-controlled trial Ann Surg 238:651–660Google Scholar
  2. 2.
    Bisgaard T, Klarskov B, Rosenberg J, Kehlet H (2001) Characteristics and prediction of early pain after laparoscopic cholecystectomy. Pain 90:261–69CrossRefPubMedGoogle Scholar
  3. 3.
    Bisgaard T, Klarskov B, Rosenberg J, Kehlet H (2001) Factors determining convalescence after uncomplicated laparoscopic cholecystectomy. Arch Surg 136:917–21CrossRefPubMedGoogle Scholar
  4. 4.
    Bisgaard T, Kristiansen VB, Hjortsø NC, Jacobsen LS, Rosenberg J, Kehlet H (2004) Randomised clinical trial comparing an oral carbohydrate beverage with placebo before laparoscopic cholecystectomy. Br J Surg 91:151–158CrossRefPubMedGoogle Scholar
  5. 5.
    Bisgaard T (2006) Analgesic treatment after laparoscopic cholecystectomy. A critical assessment of the evidence. Anesthesiology 104:835–846Google Scholar
  6. 6.
    Callery MP (2003) Preoperative steroids for laparoscopic surgery. Ann Surg 238:661–662CrossRefPubMedGoogle Scholar
  7. 7.
    Coloma M, White PF, Markowitz SC, Whitten CW, Macaluso AR, Berrisford SB, Thornton KC (2002) Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting. Effect on outcome after laparoscopic cholecystectomy. Anesthesiology 96:1346–50CrossRefPubMedGoogle Scholar
  8. 8.
    DiSanto AR, DeSante KA (1975) Bioavailability and pharmacokinetics of prednisone in humans. J Pharma Sci 64:109–112CrossRefGoogle Scholar
  9. 9.
    Egger M, Juni P, Bartlett C, for the Consort Group (2001) The Value of patient flow charts in reports of randomized controlled trials: Bibliography study. JAMA 285:1996–1999CrossRefPubMedGoogle Scholar
  10. 10.
    Feo CV, Sortini D, Ragazzi R, De Palma M, Liboni A (2006) Randomized clinical trial of the effect of preoperative dexamethasone on nausea and vomiting after laparoscopic cholecystectomy. Br J Surg 93:295–299CrossRefPubMedGoogle Scholar
  11. 11.
    Ferry JJ, Horvath AM, Bekersky I, Heath EC, Ryan CF, Colburn WA (1988) Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses. J Clin Pharmacol 28:81–87PubMedGoogle Scholar
  12. 12.
    Fujii Y, Saitoh Y, Tanaka H, Toyooka H (2000) Granisetron/dexamethasone combination for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Eur J Anaesthesiol 17:64–68PubMedGoogle Scholar
  13. 13.
    Gambertoglio JG, Frey FJ, Holford NHG, Birnbaum JL, Lizak PS, Vincenti F, Feduska NJ, Salvatierra O, Amend WJC (1982) Prednisone and prednisolone bioavailability in renal transplant patients. Kidney Int 21:621–626CrossRefPubMedGoogle Scholar
  14. 14.
    Garg V, Jusko WJ (1994) Bioavailability, reversible metabolism of prednisone and prednisolone in man. Biopharm Drug Dispos 15:163–172CrossRefPubMedGoogle Scholar
  15. 15.
    Greif R, Laciny S, Rapf B, Hickle RS, Sessler DI (1999) Supplemental oxygen reduces the incidence of postoperative nausea and vomiting. Anesthesiology 91:1246–52CrossRefPubMedGoogle Scholar
  16. 16.
    Holte K, Kehlet H ( 2002) Perioperative single dose glucocorticoid administration - pathophysiological effects and clinical implications. J Am Coll Surg 195:694–712CrossRefPubMedGoogle Scholar
  17. 17.
    Leksowski K, Peryga P, Szyca R (2006) Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A prospective randomized study. Surg Endosc 20:878–878CrossRefPubMedGoogle Scholar
  18. 18.
    Morrow SA, Stoian CA, Dmitrovic J, Chan SC, Metz LM (2004) The bioavailability of IV methyldprednisolone and oral prednisone in multiple sclerosis. Neurology 63:1079–1080PubMedGoogle Scholar
  19. 19.
    Pickup ME (1979) Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokin 4:111–128CrossRefGoogle Scholar
  20. 20.
    Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55–89CrossRefPubMedGoogle Scholar
  21. 21.
    Schwartz JI, Mukhopadhyay S, Porras AG, Viswanathan-Aiyer KJ, Adcock S, Ebel DL, Gertz BJ (2003) Effect of rofecoxib on prednisolone and prednisone in pharmacokinetics in healthy subject. J Clin Pharmacol 43:187–192CrossRefPubMedGoogle Scholar
  22. 22.
    Wang JJ, Ho ST, Liu YH, Lee SC, Liu YC, Liao YC (1999) Dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy. Br J Anaesth 83:772–75PubMedGoogle Scholar
  23. 23.
    Wang JJ, Ho ST, Tzeng JI, Tang CS (2000) The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting. Anesth Analg 91:136–39CrossRefPubMedGoogle Scholar
  24. 24.
    Wang JJ, Ho ST, Uen YH, Lin MT, Chen KT, Huang JC (2002) Small-dose dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy: a comparison of tropisetron with saline. Anesth Analg 95:229–32CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Thue Bisgaard
    • 1
    Email author
  • Svend Schulze
    • 1
  • Niels Christian Hjortsø
    • 2
  • Jacob Rosenberg
    • 3
  • Viggo Bjerregaard Kristiansen
    • 1
  1. 1.Department of Surgical GastroenterologyGlostrup University HospitalGlostrupDenmark
  2. 2.Department of Day SurgeryGlostrup University HospitalGlostrupDenmark
  3. 3.Department of Surgical GastroenterologyGentofte University HospitalGentofteDenmark

Personalised recommendations